CytoDyn announces FDA clearance of Phase II oncology trial
PremiumThe FlyCytoDyn announces FDA clearance of Phase II oncology trial
5M ago
CytoDyn appoints Melissa Palmer as lead consultant in hepatology
Premium
The Fly
CytoDyn appoints Melissa Palmer as lead consultant in hepatology
5M ago
CytoDyn appoints Max Lataillade as head of clinical development
Premium
The Fly
CytoDyn appoints Max Lataillade as head of clinical development
6M ago
CytoDyn completes FDA meeting on Phase II Study of leronlimab
PremiumThe FlyCytoDyn completes FDA meeting on Phase II Study of leronlimab
8M ago
CytoDyn Resolves Lawsuit, Secures Payments, and Clears Debt
Premium
Company Announcements
CytoDyn Resolves Lawsuit, Secures Payments, and Clears Debt
9M ago
CytoDyn announces settlement with Amarex Clinical Research
Premium
The Fly
CytoDyn announces settlement with Amarex Clinical Research
9M ago
CytoDyn to host business news update conference call
PremiumThe FlyCytoDyn to host business news update conference call
1y ago
CytoDyn says FDA has lifted clinical hold on leronlimab
Premium
The Fly
CytoDyn says FDA has lifted clinical hold on leronlimab
1y ago
CytoDyn submits revised HIV clinical trial protocol to FDA
Premium
The Fly
CytoDyn submits revised HIV clinical trial protocol to FDA
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100